1Metz C, Cave H, Bertrand AM, et al. Neonatal diabetes mellitus : chromosomal analysis in transient and permanent cases. [ J ] Pediatrics,2002,141:483489.
2Noma A. ATP- regulated K ^+ channels in cardiac muscle [ J ]. Nature, 1983,305 ( 5930 ) : 147-148.
3Inagaki N, Gonoi T, Clement IV, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor[ J ]. Science, 1995,270 ( 5239') : 1166-1170.
4Seino S, Miki T. Physiological and pathophysiological roles of ATP sensitive K-channels [ J ]. Prog Biophys Mol Biol, 2003,81 :133-176.
5Shyng SL, Nichols CG. Octameric stoichiometry of the KATP channel complex I J ]. J Gen Physiol, 1997,110:655- 664.
6Dabrowsk IM, Larsen T, Ashcroft FM, et al. Potent and selective activation of the pancreatic betacell type K ( A TP) channel by two novel diazoxide analogues [J]. Diabetologia,2003,46 (8) : 1375-1382.
7Koster JC, Marshall BA, Ensor N, et al. Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes [ J ]. Cell ,2000,100:645- 654,
8Gloyn AL, Pearson ER,Antcliff JF, et, al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes [ J ]. N Engl J Med, 2004,350 : 1838 -1849.
9Sagen JV, Raeder H, Hathout E, et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2 :patient characteristics and initial response to sulfonylurea therapy [ J ]. Diabetes,2004,53:2713-2718.
1Wolfsdorf JI.Hyperinsulinemic hypoglycemia of infancy.J Pediatr,1998,132:1-3.
2Glaser B,Chiu KC,Anker R,et al.Familial hyperinsulinism maps to chromosome 11p14-15.1,30 cM centromeric to the insulin gene.Nat Genet,1994,7:185-188.
3Thomas PM,Cote GJ,Hallman DM,et al.Homozygosity mapping,to chromosome 11p,of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy.Am J Hum Genet,1995,56:416-421.
4Thomas PM,Cote GJ,Wohllk N,et al.Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy.Science,1995,268:426-429.
5Nestorowicz A,Wilson BA,Schoor KP,et al.Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews.Hum Mol Genet,1996,5:1813-1822.
6Dunne M J,Cosgrove KE,Shepherd RM,et al.Hyperinsulinism in infancy:from basic science to clinical disease.Physiol Rev,2004,84:239-275.
7Thomas PM,Wohllk N,Huaug E,et al.Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor,and familial persisteut hyperinsulinemic hypoglycemia of infancy.Am J Hum Genet,1996,59:510-518.
8Nichols CG,Shyng SL,Nestorowicz A,et al.Adenosine diphosphate as an intracellular regulator of insulin secretion.Science,1996,272:1785-1787
9Aguilar-Bryan L,Bryan J.Molecular biology of adenosine triphosphatesensitive potassium channels.Endocr Rev,1999,20:101-135.
10Thomas P,Ye Y,Lightner E.Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy.Hum Mol Genet,1996,5:1809-1812.
2Flanagan SE, Edghill EL, Gloyn AL, et al. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia, 2006, 49 : 1190-1197.
3Flanagan SE, Patch AM, Mackay D J, et al. Mutations in ATP- sensitive K + channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes, 2007, 56 : 1930-1937.
4Rubio-Cabezas O, Klupa T, Maleeki MT. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest, 2011,41:323-333.
5Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med, 2004, 350 : 1838-1849.
6Babenko AP, Polak M, Cave H, et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med, 2006, 355:456-466.
7Gloyn AL, Diatloff-Zito C, Edghill EL, et al. KCNJll activating mutations are associated with developmental delay, epilepsy andneonatal diabetes syndrome and other neurological features. Eur J Hum Genet, 2006, 14:824-830.
8Greeley SA, Tucker SE, Naylor RN, et al. Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrinol Metab, 2010, 21: 464-472.
9Arnoux JB, de Lonlay P, Ribeiro MJ, et al. Congenital hyperinsulinism. Early Hum Dev, 2010, 86: 287-294.
10Craig TJ, Shimomura K, I-Ioll RW, et al. An in-frame deletion in Kit6.2 (KCNJll) causing neonatal diabetes reveals a site of interaction between Kit6.2 and SUR1. J Clin Endocrinol Metab, 2009, 94:2551-2557.
